▶ 調査レポート

ドラッグデリバリーシステム(DDS)の世界市場(~2026年)

• 英文タイトル:Global Drug Delivery Systems Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。ドラッグデリバリーシステム(DDS)の世界市場(~2026年) / Global Drug Delivery Systems Market Size, Status and Forecast 2020-2026 / MRC2-11QY11715資料のイメージです。• レポートコード:MRC2-11QY11715
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、96ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料はドラッグデリバリーシステム(DDS)のグローバル市場について調査・分析したレポートです。種類別(子宮内インプラント、プロドラッグインプラント、ポリマードラッグデリバリー、標的化ドラッグデリバリー)市場規模、用途別(感染症、腫瘍、泌尿器科、糖尿病、中枢神経系)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別ドラッグデリバリーシステム(DDS)の競争状況、市場シェア
・世界のドラッグデリバリーシステム(DDS)市場:種類別市場規模 2015年-2020年(子宮内インプラント、プロドラッグインプラント、ポリマードラッグデリバリー、標的化ドラッグデリバリー)
・世界のドラッグデリバリーシステム(DDS)市場:種類別市場規模予測 2021年-2026年(子宮内インプラント、プロドラッグインプラント、ポリマードラッグデリバリー、標的化ドラッグデリバリー)
・世界のドラッグデリバリーシステム(DDS)市場:用途別市場規模 2015年-2020年(感染症、腫瘍、泌尿器科、糖尿病、中枢神経系)
・世界のドラッグデリバリーシステム(DDS)市場:用途別市場規模予測 2021年-2026年(感染症、腫瘍、泌尿器科、糖尿病、中枢神経系)
・北米のドラッグデリバリーシステム(DDS)市場分析:米国、カナダ
・ヨーロッパのドラッグデリバリーシステム(DDS)市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのドラッグデリバリーシステム(DDS)市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のドラッグデリバリーシステム(DDS)市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのドラッグデリバリーシステム(DDS)市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Novartis、Amgen、Roche、Pfizer、Johnson & Johnson、Becton Dickinson、AstraZeneca、Baxter、Bayer、Boston Scientific
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Drug Delivery includes formulations, technologies, methods, and systems for transferring an active pharmaceutical ingredients into the body to safely provide therapeutic effect.

Market Analysis and Insights: Global Drug Delivery Systems Market
The global Drug Delivery Systems market size is projected to reach US$ 515230 million by 2026, from US$ 494320 million in 2020, at a CAGR of 3.9%% during 2021-2026.

Global Drug Delivery Systems Scope and Market Size
Drug Delivery Systems market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Novartis
Amgen
Roche
Pfizer
Johnson & Johnson
Becton Dickinson
AstraZeneca
Baxter
Bayer
Boston Scientific

Market segment by Type, the product can be split into
Intrauterine Implants
Prodrug Implants
Polymeric Drug Delivery
Targeted Drug Delivery
Market segment by Application, split into
Infectious Diseases
Oncology
Urology
Diabetes
CNS

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Drug Delivery Systems Revenue
1.4 Market by Type
1.4.1 Global Drug Delivery Systems Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Intrauterine Implants
1.4.3 Prodrug Implants
1.4.4 Polymeric Drug Delivery
1.4.5 Targeted Drug Delivery
1.5 Market by Application
1.5.1 Global Drug Delivery Systems Market Share by Application: 2020 VS 2026
1.5.2 Infectious Diseases
1.5.3 Oncology
1.5.4 Urology
1.5.5 Diabetes
1.5.6 CNS
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Drug Delivery Systems Market Perspective (2015-2026)
2.2 Global Drug Delivery Systems Growth Trends by Regions
2.2.1 Drug Delivery Systems Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Drug Delivery Systems Historic Market Share by Regions (2015-2020)
2.2.3 Drug Delivery Systems Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Drug Delivery Systems Market Growth Strategy
2.3.6 Primary Interviews with Key Drug Delivery Systems Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Drug Delivery Systems Players by Market Size
3.1.1 Global Top Drug Delivery Systems Players by Revenue (2015-2020)
3.1.2 Global Drug Delivery Systems Revenue Market Share by Players (2015-2020)
3.1.3 Global Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Drug Delivery Systems Market Concentration Ratio
3.2.1 Global Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Drug Delivery Systems Revenue in 2019
3.3 Drug Delivery Systems Key Players Head office and Area Served
3.4 Key Players Drug Delivery Systems Product Solution and Service
3.5 Date of Enter into Drug Delivery Systems Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Drug Delivery Systems Historic Market Size by Type (2015-2020)
4.2 Global Drug Delivery Systems Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Drug Delivery Systems Market Size by Application (2015-2020)
5.2 Global Drug Delivery Systems Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Drug Delivery Systems Market Size (2015-2020)
6.2 Drug Delivery Systems Key Players in North America (2019-2020)
6.3 North America Drug Delivery Systems Market Size by Type (2015-2020)
6.4 North America Drug Delivery Systems Market Size by Application (2015-2020)

7 Europe
7.1 Europe Drug Delivery Systems Market Size (2015-2020)
7.2 Drug Delivery Systems Key Players in Europe (2019-2020)
7.3 Europe Drug Delivery Systems Market Size by Type (2015-2020)
7.4 Europe Drug Delivery Systems Market Size by Application (2015-2020)

8 China
8.1 China Drug Delivery Systems Market Size (2015-2020)
8.2 Drug Delivery Systems Key Players in China (2019-2020)
8.3 China Drug Delivery Systems Market Size by Type (2015-2020)
8.4 China Drug Delivery Systems Market Size by Application (2015-2020)

9 Japan
9.1 Japan Drug Delivery Systems Market Size (2015-2020)
9.2 Drug Delivery Systems Key Players in Japan (2019-2020)
9.3 Japan Drug Delivery Systems Market Size by Type (2015-2020)
9.4 Japan Drug Delivery Systems Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Drug Delivery Systems Market Size (2015-2020)
10.2 Drug Delivery Systems Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Drug Delivery Systems Market Size by Type (2015-2020)
10.4 Southeast Asia Drug Delivery Systems Market Size by Application (2015-2020)

11 India
11.1 India Drug Delivery Systems Market Size (2015-2020)
11.2 Drug Delivery Systems Key Players in India (2019-2020)
11.3 India Drug Delivery Systems Market Size by Type (2015-2020)
11.4 India Drug Delivery Systems Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Drug Delivery Systems Market Size (2015-2020)
12.2 Drug Delivery Systems Key Players in Central & South America (2019-2020)
12.3 Central & South America Drug Delivery Systems Market Size by Type (2015-2020)
12.4 Central & South America Drug Delivery Systems Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis Drug Delivery Systems Introduction
13.1.4 Novartis Revenue in Drug Delivery Systems Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 Amgen
13.2.1 Amgen Company Details
13.2.2 Amgen Business Overview
13.2.3 Amgen Drug Delivery Systems Introduction
13.2.4 Amgen Revenue in Drug Delivery Systems Business (2015-2020)
13.2.5 Amgen Recent Development
13.3 Roche
13.3.1 Roche Company Details
13.3.2 Roche Business Overview
13.3.3 Roche Drug Delivery Systems Introduction
13.3.4 Roche Revenue in Drug Delivery Systems Business (2015-2020)
13.3.5 Roche Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Drug Delivery Systems Introduction
13.4.4 Pfizer Revenue in Drug Delivery Systems Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Details
13.5.2 Johnson & Johnson Business Overview
13.5.3 Johnson & Johnson Drug Delivery Systems Introduction
13.5.4 Johnson & Johnson Revenue in Drug Delivery Systems Business (2015-2020)
13.5.5 Johnson & Johnson Recent Development
13.6 Becton Dickinson
13.6.1 Becton Dickinson Company Details
13.6.2 Becton Dickinson Business Overview
13.6.3 Becton Dickinson Drug Delivery Systems Introduction
13.6.4 Becton Dickinson Revenue in Drug Delivery Systems Business (2015-2020)
13.6.5 Becton Dickinson Recent Development
13.7 AstraZeneca
13.7.1 AstraZeneca Company Details
13.7.2 AstraZeneca Business Overview
13.7.3 AstraZeneca Drug Delivery Systems Introduction
13.7.4 AstraZeneca Revenue in Drug Delivery Systems Business (2015-2020)
13.7.5 AstraZeneca Recent Development
13.8 Baxter
13.8.1 Baxter Company Details
13.8.2 Baxter Business Overview
13.8.3 Baxter Drug Delivery Systems Introduction
13.8.4 Baxter Revenue in Drug Delivery Systems Business (2015-2020)
13.8.5 Baxter Recent Development
13.9 Bayer
13.9.1 Bayer Company Details
13.9.2 Bayer Business Overview
13.9.3 Bayer Drug Delivery Systems Introduction
13.9.4 Bayer Revenue in Drug Delivery Systems Business (2015-2020)
13.9.5 Bayer Recent Development
13.10 Boston Scientific
13.10.1 Boston Scientific Company Details
13.10.2 Boston Scientific Business Overview
13.10.3 Boston Scientific Drug Delivery Systems Introduction
13.10.4 Boston Scientific Revenue in Drug Delivery Systems Business (2015-2020)
13.10.5 Boston Scientific Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Drug Delivery Systems Key Market Segments
Table 2. Key Players Covered: Ranking by Drug Delivery Systems Revenue
Table 3. Ranking of Global Top Drug Delivery Systems Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Intrauterine Implants
Table 6. Key Players of Prodrug Implants
Table 7. Key Players of Polymeric Drug Delivery
Table 8. Key Players of Targeted Drug Delivery
Table 9. Global Drug Delivery Systems Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Drug Delivery Systems Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Drug Delivery Systems Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Drug Delivery Systems Market Share by Regions (2015-2020)
Table 13. Global Drug Delivery Systems Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Drug Delivery Systems Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Drug Delivery Systems Market Growth Strategy
Table 19. Main Points Interviewed from Key Drug Delivery Systems Players
Table 20. Global Drug Delivery Systems Revenue by Players (2015-2020) (Million US$)
Table 21. Global Drug Delivery Systems Market Share by Players (2015-2020)
Table 22. Global Top Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Delivery Systems as of 2019)
Table 23. Global Drug Delivery Systems by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Drug Delivery Systems Product Solution and Service
Table 26. Date of Enter into Drug Delivery Systems Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 29. Global Drug Delivery Systems Market Size Share by Type (2015-2020)
Table 30. Global Drug Delivery Systems Revenue Market Share by Type (2021-2026)
Table 31. Global Drug Delivery Systems Market Size Share by Application (2015-2020)
Table 32. Global Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 33. Global Drug Delivery Systems Market Size Share by Application (2021-2026)
Table 34. North America Key Players Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Drug Delivery Systems Market Share (2019-2020)
Table 36. North America Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 37. North America Drug Delivery Systems Market Share by Type (2015-2020)
Table 38. North America Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 39. North America Drug Delivery Systems Market Share by Application (2015-2020)
Table 40. Europe Key Players Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Drug Delivery Systems Market Share (2019-2020)
Table 42. Europe Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Drug Delivery Systems Market Share by Type (2015-2020)
Table 44. Europe Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Drug Delivery Systems Market Share by Application (2015-2020)
Table 46. China Key Players Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 47. China Key Players Drug Delivery Systems Market Share (2019-2020)
Table 48. China Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 49. China Drug Delivery Systems Market Share by Type (2015-2020)
Table 50. China Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 51. China Drug Delivery Systems Market Share by Application (2015-2020)
Table 52. Japan Key Players Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Drug Delivery Systems Market Share (2019-2020)
Table 54. Japan Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Drug Delivery Systems Market Share by Type (2015-2020)
Table 56. Japan Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Drug Delivery Systems Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Drug Delivery Systems Market Share (2019-2020)
Table 60. Southeast Asia Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Drug Delivery Systems Market Share by Type (2015-2020)
Table 62. Southeast Asia Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Drug Delivery Systems Market Share by Application (2015-2020)
Table 64. India Key Players Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 65. India Key Players Drug Delivery Systems Market Share (2019-2020)
Table 66. India Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 67. India Drug Delivery Systems Market Share by Type (2015-2020)
Table 68. India Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 69. India Drug Delivery Systems Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Drug Delivery Systems Market Share (2019-2020)
Table 72. Central & South America Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Drug Delivery Systems Market Share by Type (2015-2020)
Table 74. Central & South America Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Drug Delivery Systems Market Share by Application (2015-2020)
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis Product
Table 79. Novartis Revenue in Drug Delivery Systems Business (2015-2020) (Million US$)
Table 80. Novartis Recent Development
Table 81. Amgen Company Details
Table 82. Amgen Business Overview
Table 83. Amgen Product
Table 84. Amgen Revenue in Drug Delivery Systems Business (2015-2020) (Million US$)
Table 85. Amgen Recent Development
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche Product
Table 89. Roche Revenue in Drug Delivery Systems Business (2015-2020) (Million US$)
Table 90. Roche Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Product
Table 94. Pfizer Revenue in Drug Delivery Systems Business (2015-2020) (Million US$)
Table 95. Pfizer Recent Development
Table 96. Johnson & Johnson Company Details
Table 97. Johnson & Johnson Business Overview
Table 98. Johnson & Johnson Product
Table 99. Johnson & Johnson Revenue in Drug Delivery Systems Business (2015-2020) (Million US$)
Table 100. Johnson & Johnson Recent Development
Table 101. Becton Dickinson Company Details
Table 102. Becton Dickinson Business Overview
Table 103. Becton Dickinson Product
Table 104. Becton Dickinson Revenue in Drug Delivery Systems Business (2015-2020) (Million US$)
Table 105. Becton Dickinson Recent Development
Table 106. AstraZeneca Company Details
Table 107. AstraZeneca Business Overview
Table 108. AstraZeneca Product
Table 109. AstraZeneca Revenue in Drug Delivery Systems Business (2015-2020) (Million US$)
Table 110. AstraZeneca Recent Development
Table 111. Baxter Business Overview
Table 112. Baxter Product
Table 113. Baxter Company Details
Table 114. Baxter Revenue in Drug Delivery Systems Business (2015-2020) (Million US$)
Table 115. Baxter Recent Development
Table 116. Bayer Company Details
Table 117. Bayer Business Overview
Table 118. Bayer Product
Table 119. Bayer Revenue in Drug Delivery Systems Business (2015-2020) (Million US$)
Table 120. Bayer Recent Development
Table 121. Boston Scientific Company Details
Table 122. Boston Scientific Business Overview
Table 123. Boston Scientific Product
Table 124. Boston Scientific Revenue in Drug Delivery Systems Business (2015-2020) (Million US$)
Table 125. Boston Scientific Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Delivery Systems Market Share by Type: 2020 VS 2026
Figure 2. Intrauterine Implants Features
Figure 3. Prodrug Implants Features
Figure 4. Polymeric Drug Delivery Features
Figure 5. Targeted Drug Delivery Features
Figure 6. Global Drug Delivery Systems Market Share by Application: 2020 VS 2026
Figure 7. Infectious Diseases Case Studies
Figure 8. Oncology Case Studies
Figure 9. Urology Case Studies
Figure 10. Diabetes Case Studies
Figure 11. CNS Case Studies
Figure 12. Drug Delivery Systems Report Years Considered
Figure 13. Global Drug Delivery Systems Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Drug Delivery Systems Market Share by Regions: 2020 VS 2026
Figure 15. Global Drug Delivery Systems Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Drug Delivery Systems Market Share by Players in 2019
Figure 18. Global Top Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Delivery Systems as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Drug Delivery Systems Revenue in 2019
Figure 20. North America Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed